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ABSTRACT
Lead is a non- biodegradable multi- organ toxicant implicated in 
various disorders including renal and hepatic diseases. In the quest for 
a cheaper and readily available antidote, this study has investigated 
the role of Solanum anomalum fruit extract in lead- induced kidney 
and liver toxicities in male albino rats. Twenty- four mature male 
albino rats were used, divided into four groups of six rats per group. 
Group 1 (control rats) received distilled water (10 ml/kg), group 2 was 
given lead acetate solution 60 mg/kg, group 3 rats were given lead 
acetate (60 mg/kg) followed by Solanum anomalum, SA (452 mg/kg) 
and group 4 rats were given lead acetate (60 mg/kg) followed by 
Solanum anomalum, SA (678 mg/kg) by oral gavage daily for 28 days. 
Animals in the lead acetate- treated group showed significant increases 
in ALT, AST, ALP, urea, bilirubin, total cholesterol, triglycerides, Low 
Density Lipoprotein, Very Low Density Lipoproteins, total white blood 
cell counts, Interleukin- 6, and decreases in body weight, packed cell 
volume, hemoglobin concentration, red blood cell count, total proteins 
and albumins. Co- administration of Solanum anomalum fruit extract 
significantly reversed most of these biomarkers. Histopathology 
of kidney and liver also points to the protective effect of Solanum 
anomalum fruit against lead induced hepato- renal damage.
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INTRODUCTION
Lead is a major cumulative toxicant that affects vari-
ous organs, causing harm particularly in children.1 
Primarily, it affects the central nervous system, 
hepatic, renal and haematopoietic systems causing 
serious disorders.2 There is currently no known safe 
blood lead concentration. Even blood lead concen-
tration as low as 5 mg/dL, once considered safe, 
may result in decreased intelligence in children, 
behavioural difficulties and learning problems.3 
Older children and adults are vulnerable to the 
severe consequences of prolonged exposure to lead, 
including increased risk of cardiovascular death 
and kidney damage later on in life.4 Lead exposure 
from the environment has been reported as a major 
risk factor for hypertension and a possible risk 
factor for mortality resulting from cardiovascular 
disease.5,6 In humans, higher blood lead levels have 
also been associated with electrocardiographic 
abnormalities, peripheral arterial disease and left- 
ventricular hypertrophy.4,7,8 Excessive dietary intake 
of lead has been linked with cancers of the kidney, 
stomach, small intestine, large intestine, ovary, 
lungs, myeloma, all lymphomas, and all leuke-
mia.9 Acute, high dose lead exposures may result 
in gastrointestinal disturbances, such as anorexia, 
nausea, vomiting and abdominal pain; neurological 
effects, such as malaise and drowsiness, as well as 
hepatic and renal damage.10 Latest report from the 
Institute for Health Metrics and Evaluation (IHME) 
shows that approximately 815 million children are 
estimated to have blood lead levels above 5μg/dL 
globally and over 900,000 premature deaths per 
year in adults,11 including 21.7 million years of 
healthy life lost (measured in Disability Adjusted 
Life Years or DALYs) as a result of the long- term 
effects of lead exposure on health.12 Exposure to 
lead accounted for about 2.9 per cent of the global 
burden of chronic kidney disease, 62.5 per cent 
of the global burden of idiopathic developmental 
intellectual disability, 8.2 per cent of the global 
burden of hypertensive heart disease, 4.6 per cent of 
the global burden of ischemic heart disease and 4.7 
per cent of the global burden of stroke.13 About 92 
per cent of all deaths attributable to lead exposures 
occur in low- and middle- income countries.14
Children from poor nations are particularly 
vulnerable to the harmful effects associated with 
lead poisoning such as those with family members 
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working in industries such as artisanal ceramic 
workshops, metal mines, informal smelting and 
lead- acid battery recycling without protective equip-
ment.15 Such children do not have access to good 
and qualitative healthcare16 and have poor nutri-
tional status such as deficiencies in calcium and iron 
that can result in increased absorption of lead.17,18,19 
The mainstay of treatment of lead poisoning is 
chelation therapy. Chelating agents contain sulf-
hydryl groups which bind or chelate lead to form a 
complex that is excreted either renally or hepatically. 
The pharmaceutical Chelating agents, e.g. Succimer 
and Penicillamine are administered orally, whereas 
Dimercaprol and edetate (EDTA) calcium disodium 
(CaNa2 EDTA) are administered parenterally. In 
addition to reducing blood lead level these classic 
chelating agents may also mobilize skeletal stores of 
lead thereby causing their redistribution and toxicity 
to other organs like the brain as well as causing other 
adverse effects.20 In addition to the adverse effects, 
the prohibitive cost and scarcity of these agents pose 
serious management challenge in resource poor 
countries in the developing nations. Hence, the need 
to explore readily available and natural antidote in 
the management of lead poisoning.
The plant, Solanum anomalum: Thonn. Ex. 
Schumach is about 2 meters in height with prick-
les up to 5mm long on stem, branches and midrib 
of the leaves. The fruit is a ball- shaped berry of 
5- 9  mm in diameter, shiny red when mature and 
green when young. The seeds are also globose 
2- 3 mm in diameter and ball- shaped.21 The mature 
red fruits of Solanum anomalum are harvested from 
the wild and made into soups and sauces, or can be 
eaten fresh. The exudate from the leaves and fruits 
is drunk or taken by enema 1- 2 times daily as a 
treatment for leprosy in West Africa. In Nigeria, the 
fruit is used as a laxative and appetizer. Anecdotal 
evidence laid claim to the usefulness of the fruits 
in the treatment of splenomegaly in children.22 The 
locals also claim that eating the raw fruits help to 
treat malaria. The leaf exudate has been used to treat 
gonorrhea, and crushed fruits extracts are used as 
anti- inflammatory and analgesic.23 Very few scien-
tific works have been done on the plant. This fruits 
contain saponins, cardiac glycosides, anthraqui-
nones, terpenes, flavonoids, tannins and alkaloids.22 
The LD50 was reported as 2260 ± 131.78mg/kg, in 
addition to the anti- diabetic effect of the ethano-
lic extract and fractions of the fruits.22 In another 
study, Offor et  al.24 reported that Solanum anom-
alum fruit extract may be a protective modulator 
of lead- induced testicular injury. The present study 
seeks to examine the protective effect of Solanum 
anomalum fruit extracts on lead- induced liver and 
kidney injuries in albino rats.
MATERIALS AND METHODS
Chemicals: Lead acetate trihydrate (May & 
Baker, England) was dissolved in distilled water; 
Thiobarbituric acid, eosin, formalin and hematoxy-
lin (Merck, Germany), Rat ELISA (Enzyme- linked 
immunosorbent assay) kits (RayBiotech, Inc. USA 
and Assaypro LLC, USA)
Animal husbandry: Twenty- four male 
albino Wistar rats, weighing 145 – 170 g (aged 
11- 15  weeks) obtained from the University of 
Uyo Animal house, were acclimatized for two 
weeks, maintained under controlled conditions 
of temperature (23 ± 2°C) and humidity (50 ± 
5%) and a 12- h light–dark cycle, were used for 
the experiment (31). The animals were housed in 
sanitized polypropylene cages containing sterile 
paddy husk as bedding. The bedding of the cages 
was changed weekly, and the cages were cleaned 
as well. They had free access to standard rat pellet 
diet and water ad libitum.25 The procedures were 
performed according to the guidelines on the 
use of animals and approved by the Institutional 
Animal Ethical Committee of the University of 
Uyo, Nigeria (Ethical Approval No: UNIUYO/
PHARM/2015/0153).
Plant collection
Solanum anomalum with the fruits was obtained 
from a farmland in Obot Ndom Itumbonuso 
village, Ini Local Government Area of Akwa Ibom 
State, Nigeria. It was identified and authenticated 
by Professor M.E.Bassey, a plant taxonomist in 
the Department of Botany and Ecological Studies, 
University of Uyo. The plant specimen (voucher 
number UUH: No 75(a)) was deposited in the 
Herbarium of the Department of Pharmacognosy 
and Natural Medicine, Faculty of Pharmacy, 
University of Uyo, Nigeria.
Preparation and Extraction
The fruits were separated from the stalk and air 
dried under room temperature for 3 weeks. The 
dried fruits were powdered using pestle and mortar. 
The extract was prepared by maceration (cold 
extraction) of 350.05g of the air- dried, powdered 
fruits of S. anomalum using 60% ethanol in distilled 
water (v/v) in an extracting jar. This set up was 
allowed to stand for 72 hours with occasional 
shaking. The extract was filtered, concentrated 
until constant weights were achieved and stored 
in a refrigerator at 2- 8°C for use in subsequent 
experiments. This procedure was repeated 3 times 
for maximal extraction (yield 69.8%). The LD50 
of Solanum anomalum was determined by Offor & 
Ubengama22 as 2260 ± 131.78 mg/kg. The chosen 
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doses were the middle dose (20% of the LD50) 
which is 452mg/kg and the high dose (30% of the 
LD50) which is 678 mg/kg.
Experimental design
The rats were divided into four groups of six rats 
per group as follows:
Group 1:  Control rats: They were given distilled 
water (10ml/kg) by oral gavage daily for 
28 days.
Group 2:  Contained lead acetate solution 60mg/kg 
by oral gavage daily for 28 days 26
Group 3:  Lead acetate (60 mg/kg), plus Solanum 
anomalum fruit extracts (452 mg/kg) by 
oral gavage daily for 28 days.
Group 4:  Lead acetate (60 mg/kg), plus Solanum 
anomalum fruit extracts (678 mg/kg) 
by oral gavage daily for 28 days. In all 
animals received Solanum anomalum 
fruit extracts 90 minutes after administra-
tion of lead.
At the end of the experiment and 24 hours after 
the last dose, animals were weighed and blood 
samples collected.
Blood sample collection
Blood sample was collected using the Orbital tech-
nique.27 Blood was collected from the retro- bulbar 
plexus of the medial canthus of the eye of the rat.28 
The blood (without anticoagulant) was kept at room 
temperature for 30 minutes to clot. Afterwards, the 
test tube containing the clotted blood sample was 
centrifuged at 3,000 revolutions per minutes for 
10 minutes. The clear serum supernatant was then 
carefully aspirated with syringe and needle and 
stored in a clean sample bottle at - 20°C until use for 
biochemical assay.
Necropsy
Blood was collected by retro orbital sinus puncture.27 
Each blood sample was divided into two portions. 
The first one was mixed well with the anticoagulant, 
dipotassium EDTA by shaking and used for hema-
tological screening. The second portion (without 
anticoagulant) was kept at room temperature for 
30 min to clot. Afterward, the clotted blood sample 
was centrifuged at 3,000 rpm for 10 min. The clear 
serum supernatant was then carefully aspirated and 
stored in a clean sample bottle for the determina-
tion of some biochemical parameters. Rats were 
sacrificed under ether anesthesia29 and concussion 
stunning involving manually applied trauma on the 
head;30 the kidney and liver were excised, weighed, 
rinsed in saline, and preserved in 10% formalin for 
histopathological study.
Hematological Screening
Total White Blood Cell Counts (TWBC), Packed 
Cell Volume (PCV), Red blood cell (RBC) count, 
Lymphocytes% (L%) and Neutrophils% (N%) were 
determined using the Hemocytometer method.31 
Hemoglobin (Hb) concentration was determined 
by the Cyanmethemoglobin method.32
Biochemical Analysis
Total serum bilirubin,33 serum total proteins,34 
serum albumins,35 serum Globulin (calculated 
by subtracting the quantity of albumins from 
that of total proteins), serum total cholesterol,36 
High Density Lipoprotein (HDLs),37 Low Density 
Lipoprotein (LDL) and Very Low Density 
Lipoproteins (VLDL),38,39 serum triglycerides,40 
serum creatinine,41 and serum urea,42,43 were 
determined. The following liver enzymes were also 
assayed: Alanine Aminotransferase (ALT) and 
Aspartate aminotransferase (AST)44 and Alkaline 
phosphatase (ALP).45
Determination of Serum Levels of Pro- 
Inflammatory Cytokines
Serum levels of pro- inflammatory cytokines (Tumor 
necrosis factor- alpha, TNF- a) and Interleukin- 6 
(IL- 6) were determined using rat ELISA (Enzyme- 
linked immunosorbent assay) kits in accordance 
with manufacturer’s recommended protocols 
(RayBiotech, Inc. USA and Assaypro LLC, USA).
Statistical Analysis
Results were expressed as mean ± standard devi-
ation, SD. Statistical analysis was carried out with 
one way analysis of variance (ANOVA) followed by 
Tukey’s HSD post hoc test. Values of p <0.05 were 
considered to be significant.
RESULTS
Effect of Solanum anomalum fruit extract 
on Body Weight, Absolute and Relative 
Organ Weights (liver and kidney) of Lead 
Acetate- treated Rats
The effects on body weight, absolute and relative 
weights of liver and kidney are shown on Table 1. 
Lead acetate administration led to significant 
decrease in body weight of rats (from 190.77g  ± 
10.95 to 164.37g ± 17.28). Administration of 
Solanum anomalum (452 and 678 mg/kg) after lead 
acetate, resulted in a dose- dependent changes in 
body weight of 172.98g±18.01 and 194.53g±27.24 
respectively. The absolute and relative weights of 
liver in the control group were 5.97g ± 0.37 and 
3.36 ± 0.19 respectively. In the lead acetate treated 
group, the absolute and relative weights of liver were 
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4.96g ± 0.14and3.00 ± 0.25 respectively; in the 452 
mg SAgroup- 6.33g±0.01 and3.49±0.23 respectively 
while that in the 678mg SA group were6.22g±0.04 
and 3.40±0.02 respectively. Similarly, the abso-
lute and relative weights of kidney in the control, 
lead acetate- treated, 452mg Solanum anomalum 
and 678mg Solanum anomalum groups were 
(0.52g ± 0.05, 0.35 ± 0.01); (0.61g ± 0.07, 0.35 ± 
0.00); (0.64g±0.21, 0.36±0.01); and (0.58g±0.01, 
0.34±0.00) respectively.
Effect of Solanum anomalum fruit extract 
on Hematological Parameters
The effect on haematological parameters is as shown 
in Table 2. Treatment of rats with lead acetate (group2) 
caused significant (p<0.05) decreased in Packed cell 
volume (PCV), Haemoglobin (Hb) concentration 
and Red blood cell (RBC) count when compared 
to control. These parameters were increased signifi-
cantly (p<0.05) in groups 3 and 4  animals which 
were given452 mg/kg and 678 mg/kg of the extract 
respectively, after lead acetate compared to the group 
given lead acetate only. The effect caused by the lower 
dose of the extract (452 mg/kg) was however, signifi-
cantly different relative to control. Rats in group 2 
(given lead acetate only) also had significant increase 
(p<0.05) in total white blood count (WBC) when 
compared to rats in the control group, while the 
total WBC in the groups treated with the two doses 
of the extract were significantly (p<0.05) decreased. 
However, there was no effect on lymphocyte and 
neutrophil percentages.
Effect of Solanum anomalum fruit extract 
on Biochemical Parameters
Table 3 shows the effect of Solanum anomalum 
on the serum levels of AST, ALP, and ALT in lead 
acetate- treated male albino rats. Rats in group 
2 showed significant (p <0.05) increase in these 
liver enzymes when compared with the normal 
control group (group 1).These liver enzymes were 
decreased dose- dependently in the two extract- 
treated groups. The effect of Solanum anomalum 
on serum total proteins, Albumins and Globulins 
in lead acetate- treated male albino Wistar rats is 
shown on Table 4. There was significant (p <0.05) 
decrease in serum total proteins and albumins in 
group 2 rats compared to those in group 1. These two 
parameters were increased significantly (p<0.05) 
in the group given the higher dose (678 mg/kg) of 
the extract. Animal group treated with 452 mg/kg 
of extract showed no significant (p>0.05) increase 
in total proteins when compared to the group 
treated with lead acetate only but caused signif-
icant (p<0.05) increase in albumins, though this 
increase is significantly (p<0.05) different from that 
of control. Serum level of globulin was however, 
not significantly (p>0.05) affected in all the groups 
compared to control.
There were significant (p<0.05) increases in 
urea and bilirubin in group 2 animals compared to 
that of rats in the control group. These parameters 
were decreased significantly (p<0.05) in the group 
treated with 678 mg/kg of the extract. The group 
treated with 452 mg/kg of extract also significantly 
(p<0.05) decreased the serum levels of bilirubin 
and urea but the decrease in urea level was not 
significant (p>0.05) when compared to the lead 
acetate- only group. There was no significant effect 
(p>0.05) on creatinine level in all groups (Table 5).
The effect on Lipid profiles is as shown in Table 6. 
Rats given lead acetate- only (group 2) showed 
significant (p<0.05) increase in total cholesterol, 
triglycerides, LDL and VLDL compared to those 
in the control group. The higher dose of the extract 
(678 mg/kg) significantly (p<0.05) decreased 
the levels of LDL, VLDL, triglycerides and total 
cholesterol when compared to the group treated 
with lead acetate only. The effect of this higher 
dose of extract was however, significantly (p<0.05) 
different relative to control. Lower dose of extract 
(452 mg/kg) caused significant (p<0.05) decrease in 
Table 1  Effect of SA extract on body weight, absolute and *relative organ weights of lead acetate- treated rats









1 (Control) Distilled water (10ml/
kg)
190.77±10.95 5.97±0.37 3.36±0.19 0.52± 0.05 0.35±0.01
2 Lead Acetate (60mg/
kg)
164.37a±17.28 4.96 ±0.14 3.00±0.25 0.61 ± 0.070 0.35±0.00
3 Lead acetate (60mg/
kg) ± SA (452 mg/kg)
172.98±18.01 6.33±0.01 3.49±0.23 0.64±0.21 0.36±0.01
4 Lead acetate (60mg/
kg) ± SA (678 mg/kg)
194.53±27.24 6.22±0.04 3.40±0.02 0.58±0.01 0.34±0.00
Data were expressed as mean ± SD.
a: significantly different when compared to the control group
(p< 0.05) (n = 6)
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the levels of only two of these parameters (VLDL 
and triglyceride) relative to the lead acetate- treated 
group, although their values were significantly 
(p<0.05) different compared to control. Generally, 
there were no significant (p>0.05) effects on HDL. 
The effects on pro- inflammatory cytokines are 
shown in table 7. Rats in group 2 showed signifi-
cant (p<0.05) increase in the pro- inflammatory 
cytokine, Interleukin 6 (IL- 6) when compared to 
control. Level of this cytokine was significantly 
(p<0.05) decreased in the two doses of the extract. 
However, there was no effect on the serum level of 
tumor necrosis factor alpha, TNF- α.
Histopathology of the Kidney and liver
Liver
The histological photomicrograph of the liver tissue 
stained with H&E techniques of Group 1 (control) 
that received distilled water 10 ml/kg by oral gavage 
daily for 28 days is shown on Figures  1A & 1B. 

















1(control) Distilled water 
(10ml/kg)
40.67 ± 1.63 16.31 ± 0.72 7.89 ± 0.18 19.24 ± 4.85 71.00 ± 3.35 26.83 ± 3.55
2 Lead Acetate 
(60mg/kg)
32.83 ± 1.29a 12.57 ± 0.66a 4.41 ± 1.05a 30.66 ± 3.40a 77.00 ± 6.42 26.33 ± 1.51
3 Lead acetate 
(60mg/kg) ± SA 
(452mg/kg)
37.75 ± 1.84a,b 14.83 ± 0.69a,b 6.76 ± 0.53a,b 22.53 ± 3.51b 73.67 ± 4.08 24.83 ± 1.84
4 Lead acetate 
(60mg/kg) ± SA 
(678mg/kg)
39.67 ±0.93b 15.23±0.42a,b 7.82±0.30b 20.35±4.87b 72.00±3.80 26.00±2.97
Data were expressed as mean ± SD.
a: significantly different when compared to the control group (p<0.05)
b: significantly different when compared to the lead acetate- treated group (p<0.05) (n=6)
Table 3  Effect of SA extract on the serum levels of Aspartate Amino Transferase (AST), Alkaline Phosphatase (ALP) 








1 (control) Distilled water (10ml/kg) 55.77 ± 0.88 180.79 ± 0.17 17.67 ± 2.05
2 Lead Acetate (60mg/kg) 76.77 ± 9.20a 211.71 ± 9.63a 35.53 ± 2.82a
3 Lead acetate (60mg/kg) ± SA 
(452mg/kg)
57.81 ± 11.43b 205.06 ± 6.50a 25.67 ± 3.77a,b
4 Lead acetate (60mg/kg) ± SA 
(678mg/kg)
56.60±1.54b 195.37 ± 9.94b 23.59±3.16b
Data were expressed as mean ± SD.
a: significantly different when compared to the control group (p<0.05)
b: significantly different when compared to the lead acetate- treated group (p<0.05) (n=6)








1 (control) Distilled water (10ml/kg) 8.55 ± 0.34 4.28 ± 0.38 4.27 ± 0.35
2 Lead Acetate (60mg/kg) 6.61 ± 0.16a 2.90 ± 0.17a 3.71 ± 0.25
3 Lead acetate (60mg/kg) ± SA 
(452mg/kg)
7.37 ± 0.78a 3.52 ± 0.25a,b 3.85 ± 0.77
4 Lead acetate (60mg/kg) ± SA 
(678mg/kg)
8.21±0.40b 3.95±0.11b 4.26±0.31
Data were expressed as mean ± SD.
a: significantly different when compared to the control group (p<0.05)
b: significantly different when compared to the lead acetate- treated group (p<0.05) (n=6)
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Liver tissue in this group shows normal central 
veins surrounded by intact hepatocytes with no 
vacuolar degeneration but only mild cellular infil-
tration. Figures 1C & 1D show the histological 
photomicrograph of the liver tissue stained with 
H&E techniques of Group 2 – Lead acetate 60 
mg/kg daily for 28 days. Liver samples from this 
group (lead acetate- treated group) showed massive 
cellular (neutrophils and lymphocytes) infiltrations 
around the peri- portal areas, some hepatocyte 
necrosis and, vacuolar degeneration of peripheral 
hepatocytes. Figures 1E &1F show the histological 
photomicrograph of the liver tissue stained with 
H&E techniques of Group 3 – Lead acetate (60 
mg/kg) followed by SA 452mg/kg) daily for 28 
days. There was massive cellular infiltration of the 
peri- portal areas with lymphocytes and only a few 
vacuolated hepatocytes on the periphery. The histo-
logical photomicrograph of the liver tissue stained 
with H&E techniques of Group 4, lead acetate (60 
mg/kg) followed by SA 678mg/kg) daily for 28 days 
is shown on Figures 1G & 1H. Liver tissues in this 
group were comparable to that in group 1, showing 
normal central veins surrounded by intact hepato-
cytes with no vacuolar degeneration and only mild 
cellular infiltration.
Kidney
The histological photomicrograph of the kidney 
stained with H&E techniques of Group 1 (control) 
that received distilled water 10 ml/kg by oral gavage 
daily for 28 days is shown in Figure 2. A with normal 
Table 6  Effects of SA extract on lipid profiles of lead acetate- treated rats
Group Treatment
Total cholesterol 
(mg/dl) HDL(mg/dl) LDL(mg/dl) VLDL (mg/dl)
Triglyceride  
(mg/dl)
1(control) Distilled water  
(10ml/kg) 
53.29 ± 5.57 22.16 ± 6.22 26.30 ± 9.21 4.94 ± 0.47 24.17 ± 2.84
2 Lead Acetate  
(60mg/kg)
78.51 ± 13.66a 22.62 ± 5.00 40.07 ± 4.92a 22.64 ± 12.64a 113.20 ± 63.17a
3 Lead acetate (60mg/
kg) ± SA (452mg/kg)
74.32 ± 9.69a 26.07 ± 3.27 33.81 ± 7.53a 14.03 ± 6.26ab 75.70 ± 26.00ab
4 Lead acetate (60mg/
kg) ± SA (678 mg/kg)
68.40±4.94ab 26.64±6.72 28.46±8.60b 12.69±5.89ab 58.33±24.20ab
Data were expressed as mean ± SD.
a: significantly different when compared to the control group (p<0.05)
b: significantly different when compared to the lead acetate- treated group (p<0.05) (n=6)
Table 7  Effect of SA extract on Pro- inflammatory cytokines of lead acetate- treated rats
Group Factor Treatment Interleukin 6 (IL- 6) Tumour Necrosis (TNF- α)
1 (control) Distilled water (10ml/kg) 74.41 ± 5.45 0.01 ± 0.00
2 Lead Acetate (60mg/kg) 113.58 ± 13.46a 0.00 ± 0.00
3 Lead acetate (60mg/kg) ± SA (452mg/kg) 81.68 ± 20.50b 0.00 ± 0.00
4 Lead acetate (60mg/kg) ± SA (678 mg/kg) 76.65±7.18b 0.01±0.00
Data were expressed as mean ± SD.
a: significantly different when compared to the control group (p<0.05)
b: significantly different when compared to the lead acetate- treated group (p<0.05) (n=6)
Table 5  Effect of SA extract on the serum levels of Urea, Creatinine and Bilirubin of lead acetate- treated rats





1 (control) Distilled water (10ml/kg) 17.92 ± 2.83 0.59 ± 0.08 0.27 ± 0.11
2 Lead Acetate (60mg/kg) 29.00 ± 3.23a 0.64 ± 0.05 0.97 ± 0.31a
3 Lead acetate (60mg/kg) ± SA 
(452mg/kg)
24.95 ± 5.81a 0.63 ± 0.10 0.45 ± 0.09b
4 Lead acetate (60mg/kg) ± SA 
(678mg/kg)
17.76±4.48b 0.55±0.07 0.33±0.14b
Data were expressed as mean ± SD.
a: significantly different when compared to the control group (p<0.05)
b: significantly different when compared to the lead acetate- treated group (p<0.05) (n=6)
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dilated tubules and glomeruli at the periphery of 
the cortex. Figures 2B & 2C show the histological 
photomicrograph of the kidney tissue stained with 
H&E techniques of Group 2 – Lead acetate 60 mg/
kg daily for 28 days. The kidney tissue in this group 
shows degeneration and necrosis of the renal paren-
chymal cells with massive inflammatory cells infil-
tration. The kidney of rats in Group 2 – Lead acetate 
60 mg/kg daily for 28 days showed areas of degener-
ation and necrosis of the renal cortical parenchymal 
cells with massive lymphocytic cellular infiltration, 
with vacuolar degeneration of the peripheral inter-
stitial cells of the cortex. Tissue sections from the 
kidneys of rats in Group 3 – Lead acetate (60 mg/
kg) followed by SA 452 mg/kg daily for 28 days 
showed areas of lymphocytic cellular infiltration, 
haemorrhage, necrosis and mild vacuolar degener-
ation of the peripheral interstitial cells of the cortex, 
but the medullary tubules were normal (Figure 2D). 
The histological photomicrograph of the kidney 
tissue stained with H&E techniques of Group 4, 
lead acetate (60 mg/kg) followed by SA 678mg/
kg) daily for 28 days is shown on Figures 2E & 2F. 
Kidney tissues show normal dilated tubules in the 
periphery of the cortex and normal glomeruli with 
light lymphocytic cellular infiltration.
DISCUSSION
The ubiquity and non- biodegradability of lead 
coupled with its multi organ toxicity is a great 
public health concern. This toxicity of lead includes 
its effect on the liver and kidney. Toxic effects on 





























































Figure 1  (A) Histological photomicrograph of the liver tissue stained with H&E techniques of Group 1 (control) that received 
distilled water 10 ml/kg by oral gavage daily for 28 days – Central veins with normal, intact hepatocytes surrounding it 
(1A Mag × 160). (B) Histological photomicrograph of the liver tissue stained with H&E techniques of Group 1 (control) 
that received distilled water 10 ml/kg by oral gavage daily for 28 days – Intact hepatocytes on the periphery with no 
vacuolar degenerations (1B Mag × 640). (C) Histological photomicrograph of the liver tissue stained with H&E techniques 
of Group 2 – Lead acetate 60 mg/kg daily for 28 days – Massive cellular infiltration around the portal areas with some 
hepatocyte necrosis (1C Mag × 160). (D) Histological photomicrograph of the liver tissue stained with H&E techniques 
of Group 2 – Lead acetate 60 mg/kg daily for 28 days – Vacuolar degeneration of peripheral hepatocytes, massive cellular 
infiltration and hepatocyte necrosis (1D Mag × 640). (E) Histological photomicrograph of the liver tissue stained with H&E 
techniques of Group 3 – Lead acetate (60 mg/kg) followed by SA 452 mg/kgdaily for 28 days- Massive cellular infiltration 
of the peri- portal areas with lymphocytes (1E Mag × 160). (F) Histological photomicrograph of the liver stained with H&E 
techniques of Group 3 – Lead acetate (60 mg/kg) followed by SA 452 mg/kg daily for 28 days – Massive cellular infiltration 
of the peri- portal areas with lymphocytes and only a few vacuolated hepatocytes on the periphery (1F Mag × 640). (G) 
Histological photomicrograph of the liver stained with H&E techniques of Group 4 – Lead acetate (60 mg/kg) followed by 
SA 678 mg/kg daily for 28 days – normal central veins surrounded by intact hepatocytes(1G Mag × 160). (H) Histological 
photomicrograph of the liver stained with H&E techniques of Group 4 – Lead acetate (60 mg/kg) followed by SA 678 mg/
kg daily for 28 days – mild cellular infiltration with no vacuolar degeneration(1H Mag × 640)
   Key: CV- central vein, CI- cellular infiltration, s- sinusoid, H- hepatocytes and V- vacuolization.
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changes in the excretory function.46,47,48 Lead that 
is absorbed is conjugated in the liver and passed 
to the kidney, where a small amount is excreted 
in urine and the rest accumulates in various body 
organs and affects many biological activities at the 
molecular, cellular and intercellular levels, resulting 
in morphological changes that persist even after the 
levels of lead have fallen.49 Solanum anomalum fruit 
extract is investigated in this study as a possible 
alternative to the classical antidotes owing to their 
numerous limitations which include many adverse 
effects (painful, hepatotoxicity, gastrointestinal 
symptoms), difficulties in their administration, 
not readily available and being expensive, among 
others.
In this study, lead acetate administration 
resulted in a significant decrease in body weight, 
while the administration of Solanum anomalum 
(452 and 678 mg/kg) after lead acetate resulted 
in a dose- dependent changes in body weight but 
no significant changes in the absolute and rela-
tive organ weights of the liver and kidney. The 
alteration in overall body weight or organ- body 
weight ratio is an indication of impairment in the 
normal functioning of the organs. Body weights are 
widely accepted for the evaluation of test- articles 
associated toxicities.50 Treatment of rats with lead 
acetate in this study also caused significant reduc-
tion in packed cell volume (PCV), Haemoglobin 
(Hb) concentration and Red blood cell (RBC) 
count. Results of this study are in agreement with 
the findings of Nabil et  al.,51 Hanan and Riham. 
On the other hand, total WBC was significantly 
increased. Administration of the two doses of the 
extract (452 mg/kg and 678 mg/kg) respectively, 
caused significant increases in PCV, Hb and RBC as 
well as significant decrease in WBC. Lead directly 
affects the haematopoietic system by restraining 
the synthesis of haemoglobin through inhibition of 
various key enzymes involved in the heme synthesis 
pathway, particularly the enzyme Aminolevulinic 
Acid Dehydratase (ALAD). It also reduces the life 
span of circulating erythrocytes by increasing the 
fragility of cell membranes. The aftermaths of these 
two processes result in anaemia.53,54
Treatment of rats with lead acetate caused 
significant increase in the activity of serum AST, 
ALT, ALP, bilirubin and urea, while the levels of 
albumin and total proteins were decreased. Similar 
results were reported by Azoz and Raafat,55 Ibrahim 
et al.56 and Azab.57 These parameters were however, 
reversed by treatment with the two doses of Solanum 
anomalum extract used in this study. Increasing 
levels of AST and ALT in the animals treated with 
lead acetate signify damage to the structural integ-





















Figure 2: (A) Histological photomicrograph of the kidney stained with H&E techniques of Group 1 – control 
that received distilled water 10 ml/kg via oral gavage daily for 28 days – Normal dilated tubules and glomeruli 
at the periphery of the cortex (2A Mag x 160). (B) Histological photomicrograph of the kidney tissue stained 
with H&E techniques of Group 2 – Lead acetate 60 mg/kg daily for 28 days –Degeneration and necrosis of the 
renal parenchymal cells (2B Mag x 160). (C) Histological photomicrograph of the kidney tissue stained with 
H&E techniques of Group 2 – Lead acetate 60 mg/kg daily for 28 days – Massive lymphocytic cellular 
infiltration, with degeneration and necrosis (2C Mag x 640). (D) Histological photomicrograph of the kidney 
stained with H&E techniques of Group 3 – Lead acetate (60 mg/kg) followed by SA 452 mg/kg daily for 28 
days –Showed areas of lymphocytic cellular infiltration, haemorrhage, necrosis and mild vacuolar degeneration 
of the peripheral interstitial cells of the cortex, normal medullary tubules (2D Mag x 160). (E) Histological 
photomicrograph of the kidney stained with H&E techniques of Group 4 – Lead acetate (60 mg/kg) followed by 
SA 678 mg/kg daily for 28 days – normal dilated tubules in the periphery of the cortex and normal glomeruli 


















Figure 2  (A) Histological photomicrograph of the kidney stained with H&E 
techniques of Group 1 – control that received distilled water 10 
ml/kg via oral gavage daily for 28 days – Normal dilated tubules 
and glomeruli at the periphery of the cortex (2A Mag × 160). (B) 
Histological photomicrograph of the kidney tissue stained w th H&E 
techniques of Group 2 – Lead acetate 60 mg/kg daily for 28 days –
Degeneration and necrosis of the renal parenchymal cells (2B Mag × 
160). (C) Histological photomicrograph of the kidney tissue stained 
with H&E techniques of Group 2 – Lead acetate 60 mg/kg daily for 
28 days – Massive lymp ocytic cellular infiltra ion, with degeneration 
and necrosis (2C Mag × 640). (D) Histological photomicrograph of 
the kidney stained with H&E techniques of Group 3 – Lead acetate 
(60 mg/kg) followed by SA 452 mg/kg daily for 28 days –Showed 
areas of lymphocytic cellular infiltration, haemorrhage, necrosis and 
mild vacuolar degeneration of the peripheral interstitial cells of the 
cortex, normal medullary tubules (2D Mag × 160). (E) Histological 
photomicrograph of the kidney stained with H&E techniques of 
Group 4 – Lead acetate (60 mg/kg) followed by SA 678 mg/kg daily 
for 28 days – normal dilated tubules in the periphery of the cortex 
and normal glomeruli with light lymphocytic cellular infiltration (2E 
Mag × 160). (F) Histological photomicrograph of the kidney stained 
with H&E techniques of Group 4 – Lead acetate (60 mg/kg) followed 
by SA 678 mg/kg daily for 28 days – normal dilated tubules and normal 
glomeruli with mild lymphocytic cellular infiltration (2F Mag × 640).
   Key: G- glomerulus, BS- Bowman’s space, Rc- renal corpuscle, PCT- 
proximal convoluted tubule, DCT- Distal convoluted tubule, Ct- 
convoluted tubule, H- Haemorrhage
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these enzymes from the liver cytosol into the blood 
stream.58 Releasing of AST and ALT from the cell 
cytosol can occur as secondary changes to cellular 
necrosis.59 The high AST and ALT activities are 
accompanied by high liver microsomal membrane 
fluidity, free radical generation and alteration in the 
liver tissue.56 Elevated level of ALP suggests biliary 
damage or an obstruction of the biliary tree, which 
disrupts the flow of blood to the liver.60 The decrease 
in serum levels of these enzymes may be due to the 
prevention of their leakage from the liver cytosol 
by Solanum anomalum, probably due to reduction 
in blood lead level. The increase of bilirubin values 
in animals treated with lead acetate in this study 
may be the result of excessive heme destruction and 
blockage of biliary tract resulting in inhibition of 
the conjugation reaction and release of unconju-
gated bilirubin from damaged hepatocytes.61
In this study, administration of lead acetate 
caused significant increase in serum urea level, 
but only a slight increase in serum creatinine level. 
Serum urea was significantly decreased with the 
respective administration the two doses of Solanum 
anomalum, but only a slight decrease in the value 
of creatinine. Urea and creatinine levels are gener-
ally used as suitable indicators of renal function. 
Creatinine is a break down product of creatine 
phosphate in muscle and for the most part, creati-
nine is cleared from the blood entirely by the kidney. 
Decreased kidney creatinine clearance results in a 
rise in blood creatinine. On the other hand, urea is 
the major nitrogenous end product of protein and 
amino acid catabolism which is produced by the 
liver.62 Creatinine and urea elevation are biomark-
ers of abnormal renal function. However, serum 
creatinine is a later indicator of renal impairment 
as renal function is decreased by 50% before a rise 
in serum creatinine is observed.63
Lead acetate caused a significant decrease in 
the values of serum total proteins and Albumins. 
Supplementation with 678 mg/kg of Solanum 
anomalum in this study was able to significantly 
increase these parameters. The lower dose of the 
extract (452 mg/kg) also caused significant increase 
in albumin level. Decrease in serum total protein 
may be the result of hepatic and renal damage 
induced by lead,64 or binding of lead to plasma 
proteins, leading to alteration in a high number 
of enzymes and can also disturb protein synthesis 
in hepatocytes.65 Low level of serum total protein 
has also been attributed to a reduction in hepatic 
DNA and RNA induced by lead intoxication or 
as a result of decreased utilization of free amino 
acids for protein synthesis.66 Albumin is the body’s 
major serum- binding protein synthesized only in 
hepatic cells. Hypoalbuminaemia is due to several 
conditions such as nephrotic syndrome, hepatic 
cirrhosis, heart failure, and malnutrition. However, 
most cases of hypoalbuminaemia are due to acute 
and chronic inflammatory responses.67 In this study, 
administration of lead acetate was found to cause 
elevation of Total cholesterol, triglycerides, LDL 
and VLDL. This result agrees with that reported 
by Azoz and Raafat.55 The high lipid levels could 
stem from either increased synthesis or decreased 
removal of lipoproteins. Decreased removal may 
be due to the alteration of cell – surface receptors 
for lipoprotein.68 or as a result of the inhibition of 
hepatic lipoprotein lipase activity.69 The higher 
dose of the extract (678 mg/kg) caused significant 
reduction in all four lipid parameters mentioned 
above, while the extract’s lower dose (452 mg/kg) 
only decreased the levels of triglyceride and VLDL. 
Although the two doses of the extract did not show 
any significant effect on HDL in this study, their 
effects in significantly lowering the high values 
of LDL, triglycerides and total cholesterol may 
reduce the risk of development of heart disease. 
Administration of lead acetate caused signifi-
cant increase in the pro- inflammatory cytokine, 
Interleukine- 6, IL- 6. The serum level of another 
pro- inflammatory cytokine, Tumour necrosis 
factor- alpha (TNF- alpha) was undetectable in this 
study. However, administration of fruit extracts 
of Solanum anomalum significantly reduced the 
level of IL- 6. Hence, the extract of Solanum anom-
alum could protect from lead acetate- induced 
toxicity by attenuating the increased serum IL- 6. 
Measurements of cytokines and other inflammatory 
biomarkers can provide predictive clinical informa-
tion and insights into disease mechanisms.70 In our 
previous study, one of the mechanisms of protec-
tion by Solanum anomalum fruit extract involved 
elevation of antioxidant enzymes level to mitigate 
lead- induced reactive oxygen species, ROS that can 
cause oxidative organ damage.24 This was attribut-
able to its content of bioactive ingredients, includ-
ing flavonoids. The liver and kidney of rats treated 
with lead acetate followed by supplementation with 
Solanum anomalum fruit extract demonstrated 
marked improvement in their histoarchitecture and 
with less pathological changes in comparison to the 
lead acetate group.
CONCLUSION
In conclusion, Solanum anomalum fruits tend 
to be protective against liver and kidney injuries 
induced by chronic exposure to lead. Modulation 
of Interleukin- 6, a pro- inflammatory cytokine 
and mitigation of lead- induced alteration in 
some biochemical and hematological parameters 
www.phytomedicine.ejournals.ca Discovery Phytomedicine 2021; 8(2): 56-66. doi: 10.15562/phytomedicine.2021.161 65
Hepato- Renal Effect Of Solanum Anomalum Thonn. Ex. Schumach ... Samuel J. Offor, et al.
following administration of the extract, may form 
part of the mechanisms of hepato- renal protection. 
Further studies may be necessary to elucidate the 
precise mechanism(s) of action.
REFERENCES
1. WHO, World Health Organization. Lead poisoning 
and health. 2019. Available from: https://www.who.int/
news-room/fact-sheets/detail/lead-poisoning-and-health.
2. Kalia K, Flora SJ. Strategies for safe and effective thera-
peutic measures for chronic arsenic and lead poisoning. J 
Occup Health. 2005; 47:1–21. doi: 10.1539/joh.47.1
3. WHO, World Health Organization, “Lead Poisoning 
and Health. 2020. Available from: https://www.who.int/
mediacentre/factsheets/fs379/en/.2016.
4. Lanphear BP, Rauch S, Auinger P, Allen RW, Hornung RW. 
Low- Level Lead Exposure and Mortality in US Adults: 
A Population- Based Cohort Study, The Lancet Public 
Health.2018; 4(3): e177- e184.
5. Vaziri ND, Mechanisms of lead- induced hypertension and 
cardiovascular disease. Am J Physiol Heart Circ Physiol. 
2008; 295:H5454- H5465.
6. EPA, United States Environmental Protection Agency. 
Air quality criteria for lead (final report).2006.
Availablefrom: https://cfpub.epa.gov/ncea/risk/recordis-
play.cfm?deid=158823, 2006.
7. Lustberg M, Silbergeld, E. Blood lead levels and mortality. 
Arch Intern Med. 2002; 162: 2443- 2449.
8. Menke A, Muntner P, Batuman V, Silbergeld EK, Guallar E. 
Blood lead below 0·48 μmol/L (10 μg/dL) and mortality 
among US adults. Circulation. 2006;114: 1388- 1394.
9. Reddy SB, Charles MJ, Raju GJ, Deddy, BS, Reddy TS, 
Lakshmi, PV. Trace elemental analysis of cancer- afflicted 
intestine by PIXE technique. Biol. Trace Elem. Res. 
2004;102: 265–281. doi: 10.1385/BTER:102:1-3:265.
10. WHO, World Health Organization. Exposure to Lead: 
A Major Public Health Concern. 2010. Available from: 
https://www.who.int/ipcs/features/lead.pdf.
11. IHME, Institute of Health Metrics and Evaluation. 
The global burden of disease dataset for 2019. 2019a. 
Available  from: http://ghdx.healthdata.org/gbd-results-
tool, 20019a.
12. IHME, Institute for Health Metrics and Evaluation. GBD 
Compare - Data Visualizations. 2019b. Available from: 
http://vizhub.healthdata.org/gbd-compare.
13. Stanaway JD, Afshin A, Gakidou E, Lim SS, Abate D, 
KalkidanHassen AKH, Abbafati C et al. Global, Regional, 
and National Comparative Risk Assessment of 84 
Behavioural, Environmental, Occupational, and Metabolic 
Risks or Clusters of Risks for 195 Countries and Territories, 
1990–2017: A Systematic Analysis for the Global Burden 
of Disease Study 2017.The Lancet. 2018; 10159(392): 1923- 
1994. DOI: 10.1016/S0140-6736(18)32225-6.
14. IHME, Institute for Health Metrics and Evaluation, GBD 
Compare – Data Visualizations. 2018. Available from: 
http://vizhub.healthdata.org/gbd-compare.
15. Ceballos D, Franck M. “Are You Bringing Toxic 
Chemicals Home from Work?” (Hoffman Program on 
Chemicals and Health. Harvard T.H. Chan School of 
Public Health). 2015. Available from: https://sites.sph.
harvard.edu/hoffman-program/2015/12/07/are-you 
bringing-toxic-chemicals-home-from-work/.
16. Ness TE, Rowan BH. “Lead Poisoning: How what we don’t 
know is hurting America’s children- Harvard Public Health 
Review. 2016. Available from: http://harvardpublicheal 
threview.org/lead-poisoning/.
17. Patrick L. Lead toxicity, a review of the literature. Part I: 
Exposure, evaluation, and treatment. Altern Med Rev. 
2006. PMID: 16597190.
18. Mahaffey KR. Nutrition and lead: Strategies for Public 
health. Environ. Health Perspect. 1995; 103 (Suppl. 6): 
191–196. DOI: 10.1289/ehp.95103s6191.
19. Eleese C. What role does nutrition play in the prevention 
or treatment of childhood lead poisoning? Journal of the 
Academy of Nutrition and Dietetics. 2012; 112(11): DOI: 
10.1016/j.jand.2012.09.003.
20. Kathuria P. Lead toxicity medication. Medscape. 2020. 
Available from: https://emedicine.medscape.com/arti-
cle/1174752-medication, 2020.
21. Irvine FRJ. Woody plants of Ghana, with special references 
to their uses, Oxford University Press, London, United 
Kingdom. 1969. pp. 868- 869.
22. Offor SJ, Ubengama E. Phytochemical and Antidiabetic 
studies of ethanolic extracts and fractions of the fruits of 
Solanum anomalum. International Journal of Scientific 
Research and Education. 2015; 3: 4343- 4350.
23. Bukenya ZR, Hall JB. Solanum (Solanaceae) in Ghana. 
Bothalia. 1988; 18:79- 88.
24. Offor SJ, Mbagwu HOC, Orisakwe OE. Improvement of 
lead acetate- induced testicular injury and sperm quality 
deterioration by Solanum anomalum Thonn.Ex. Schumach 
Fruit Extracts in Albino Rats. J Fam Reprod Health. 2019; 
13(2): 98- 108.
25. Offor SJ, Mbagwu HOC, Orisakwe OE. Lead- induced 
Hepato- renal Damage in Male Albino Rats and Effects 
of Activated Charcoal. Frontiers in Pharmacology. 2017; 
8:107.
26. Cheong MJ, Roh YB. The Protective Effects of Activated 
Charcoal on the acute damages of kidney of mouse by lead. 
Korean J Electron Microscopy. 2006; 36:57- 72.
27. Stone SH. Method for obtaining venous blood from 
the orbital sinus of a rat or mouse. Science. 1954; 119: 
100 –102.
28. Odo RI Mbegbu EC, Nwosu KC, Aba PE, Aka LO, 
Obidike IR. Effect of cement dust on reproductive perfor-
mance and some physiological parameters in albino rats. 
Comp Clin Path. 2015; 24: 521- 526.
29. Okolo KO, Siminialayi IM, Orisakwe OE. Protective 
effects of Pleurotus tuber- regium on Carbon- tetrachloride 
induced testicular injury in Sprague Dawley Rats. Front. 
Pharmacol. 2016; 7:480. doi: 10.3389/fphar.2016.00480.
30. AVMA, AVMA Guidelines for the Euthanasia of Animals, 
2013 Edn. Schaumburg, IL: American Veterinary Medical 
Association.
31. Thrall MA, Weiser MG. Hematology in Laboratory 
Procedures for Veterinary Technicians, 4th Edn, ed. C. M. 
Hendrix (Saint Louis: MO: Mosby). 2002; pp. 29–74.
32. Higgins T, Beutler E, Doumas BT. Measurement of hae-
moglobin in blood, in Tietz Fundamentals of Clinical 
Chemistry, 6th Edn, eds C. A. Burtis, E. R. Ashwood, and 
D. E. Bruns (Saint Louis: MO: Sanders Elsevier). 2008; 
524–525.
33. Doumas BT, Perry BW, Sasse EA, Straumfjord Jr. JV. 
Standardization in bilirubin assays: evaluation of selected 
methods and stability of bilirubin solutions. Clinical 
Chemistry. 1973; 19: 984–993.
34. Lubran MM. The measurement of total serum proteins by 
the Biuret method. Ann. Clin. Lab. Sci. 1978; 8: 106–110.
35. Doumas BT, Peters Jr. T. Serum and urine albumin: a 
progress report on their measurement and clinical signif-
icance. Clin. Chim. Acta. 1997; 258: 3–20. doi: 10.1016/
S0009-8981(96)06446-7
36. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. 
Enzymatic determination of total cholesterol. Clin. Chem. 
1974; 20: 470–475.
37. Albers JJ, Warnick GR, Cheung MC. Quantification of 
high density lipoproteins. Lipids. 1978; 13: 926–932. doi: 
10.1007/BF02533852.
38. Friedewald WT, Levy RI, Fredrickson DS. Estimation of 
the concentration of low density lipoprotein cholesterol 
in plasma, without use of the preparative ultra- centrifuge. 
Clin. Chem. 1972; 18: 499–502.
39. Warnic, GR, Knopp RH, Fitzpatrick V, Branson L. 
Estimating low- density lipoprotein cholesterol by the 
Friedewald equation is adequate for classifying patients 
on the basis of nationally recommended cut points. Clin. 
Chem. 1990; 36: 15–19.
66 Discovery Phytomedicine 2021; 8(2): 56-66. doi: 10.15562/phytomedicine.2021.161 www.phytomedicine.ejournals.ca
Hepato- Renal Effect Of Solanum Anomalum Thonn. Ex. Schumach ... Samuel J. Offor, et al.
40. Bucolo G, David H. Quantitative determination of serum 
triglyceride by use of enzymes. Clin Chem. 1973; 19: 
476–482.
41. Blass, KG, Thiebert RJ, Lam LK. A study of the mechanism 
of the Jaffe reaction. J. Clin. Chem. Clin. Biochem. 1974; 
12: 336–343. doi: 10.1515/cclm.1974.12.7.336
42. Fawcett JK, Scott JE. A rapid and precise method for the 
determination of urea. J Clin Pathol. 1960; 13: 156–159. 
doi: 10.1136/jcp.13.2.156.
43. Searcy RL, Reardon JE, Foreman JA. A new photometric 
method for serum urea nitrogen determination. Am. J. 
Med. Technol. 1967; 33: 15–20, 1967.
44. Reitman S, Frankel S. A colorimetric method for determi-
nation of serum glutamic oxaloacetic and glutamic pyruvic 
transaminases. Am. J. Clin. Pathol. 1957; 28: 56–62. doi: 
10.1093/ajcp/28.1.56
45. Babson AL, Greeley SJ, Coleman CM, Philips GE. 
Phenolphthalein monophosphate as a substrate for serum 
alkaline phosphatase. Clin. Chem. 1966; 12: 482–490.
46. Abdou HM, Hassan MA. Protective role of omega- 3 poly-
unsaturated fatty acid against lead acetate- induced toxic-
ity in liver and kidney of female rats. Biomed Res. 2014; 
435857.
47. Yuan G. Dai S, Yin Z, Lu H, Jia R, Xu J, Song X, Li L, Shu Y, 
Zhao X. Toxicological assessment of combined lead and 
cadmium: Acute and sub- chronic toxicity study in rats. 
Food Chem Toxicol. 2014; 65: 260–268.
48. Cobbina SJ, Chen Y, Zhou Z, Wu X, Zhao T, Zhang Z, 
Feng  W, Wang W et  al. Toxicity assessment due to sub- 
chronic exposure to individual and mixtures of four toxic 
heavy metals. J. Hazard. Mater. 2015; 294: 109–120.
49. Flora S, Flora G, Saxena G. Environmental occurrence, 
health effects and management of lead poisoning. In: 
Casas JS, Sordo J, editors. Lead: chemistry, analytical aspects, 
environmental impact and health effects,” Amsterdam, 
Netherlands: Elsevier Science. 2006; 158–228.
50. UNL, University of Nebraska. Environmental health and 
safety toxicology and exposure guidelines. 2002; 402: 
472- 925.
51. Nabil MI, Esam AE, Hossams E, Yasmin EA. Effect of lead 
acetate toxicity on experimental male albino rat. Asian Pac. 
J. Trop.Biomed. 2012; 2(1):41- 46.
52. Hanan AA, Riham MR. Effect of Lead Toxicity on 
Cytogenisity, Biochemical Constituents and Tissue 
Residue with Protective Role of Activated Charcoal and 
Casein in Male Rats. Aust. J. Basic Appl. Sci. 2012; 7(6): 
497- 509.
53. Guidotti, TL, McNamara J, Moses MS. The interpretation 
of trace element analysis in body fluids. Indian Journal of 
Medical Research. 2008; 128:524–532.
54. Flora G, Gupta D, Tiwari A. Toxicity of Lead: A review 
with recent updates,” Interdiscip Toxicol. 2012; 5(2): 47- 58.
55. Azoz HA, Raafat RM. Effect of lead toxicity on cytogenis-
ity, biochemical constituents and tissue residue with pro-
tective role of activated charcoal and casein in male rats. 
Aust. J. Basic Appl. Sci. 2012; 6: 497–509.
56. Ibrahim NM, Eweis EA, El- Beltagi HS, Abdel- Mobdy YE. 
Effect of lead acetate toxicity on experimental male albino 
rat. Asian Pac. J. Trop.Biomed. 2012; 2: 41–46. doi: 10.1016/
S2221-1691(11)60187-1
57. Azab EA. Hepatoprotective effect of sesame oil against lead 
induced liver damage in albino mice: histological and bio-
chemical studies. Am. J. Biosci. 2014; 2: 1–11.
58. Concepcion NM, Pilar MM, Martin A, Jimenez J, 
Pillar  UM. “Free radical scavenger and anti- hepatotoxic 
activity of Rosmarinu stomentosus. Planta Medica. 1993; 
59: 312- 314.
59. Gaskill, CL, Miller LM, Mattoon JS. Liver histopathology 
and liver and serum alanine aminotransferase and alkaline 
phosphatase activities in epileptic dogs receiving pheno-
barbital. Vet. Pathol. 2005; 42: 147–160. doi: 10.1354/
vp.42-2-147
60. Farida, T, Salawu OA, Tijani AY, Ejiofor JI. Pharmacological 
evaluation of Ipomea asarifolia (Desr.) against car-
bon tetrachloride- induced hepatotoxicity in rats. J 
Ethnopharmacol. 2012; 142: 642- 646.
61. Ali ZY, Atia HA, Ibrahim NH. Possible Hepatoprotective 
potential of Cynarascolymus, Cupressussempervirens and 
Eugenia jambolana against paracetamol- induced liver 
injury: In- vitro and In- vivo evidence. Nat.Sci. 2010; 75–86.
62. Gowda S, Desai, PB, Kulkarni SS, Hull VV, Math AAK, and 
Vernekar SN. Markers of renal function tests. N Am J Med 
Sci. 2010; 4(2): 170–173.
63. Gounden V, Jialal I. Renal function tests. Stat Pearls 
[Internet]. 2019. Available from: https://www.ncbi.nlm.
nih.gov/books/NBK507821/.
64. Ahmed YF, Shalaby SIA. Clinicopathological and histo-
pathological studies on chronic lead intoxicated in male 
Bakri sheep. Afr J Agric Res.1999; 18: 19- 37.
65. Goering PL. Lead- protein interactions as a basis for lead 
toxicity. Neurotoxicol. 1993; 14: 45- 60.
66. Moussa SA, Bashandy SA. Biophysical and biochemical 
changes in the blood of rats exposed to lead toxicity. Rom J 
Biophys. 2008; 18: 123- 133.
67. Peralta R, Rubery BA, Talavera F, Manning HL, Pinsky MR, 
Sharma S. Hypoalbuminemia. 2018. Available from: https://
emedicine.medscape.com/article/166724-overview.
68. Tarugi P, Calandra S, Borella P, Vicvoli GF. Effect of lead 
intoxication on rabbit plasma lipoproteins. Atherosclerosis. 
1982; 45: 221- 234.
69. Chajet ST, Friedman G, Stein O, Shiloni F, Etienne J, 
Stein Y. Mechanism of the hyperteriglyceridemia induced 
by tumor necrosis factor administration to rats. Biochimica 
et Biophysica Acta. 1989; 1001: 316 – 324.
70. Zhou X, Fragala MS, McElhaney JE, Kuchel GA. 
Conceptual and methodological issues relevant to cytokine 
and inflammatory marker measurements in clinical 
research. Cur Opin Clinical Nutr Metab Care. 2010; 13(5): 
541- 547.
This work is licensed under a Creative Commons Attribution- Non Commercial- No 
Derivatives 4.0 International License. To view a copy of this license,  
visit http://creativecommons.org/licenses/by- nc- nd/4.0/
